Skip to content

Evaluation of intracranial vascular morphological changes and the whole-brain perfusion in isolated vertigo

Evaluation of intracranial vascular morphological changes and the whole-brain perfusion in isolated vertigo

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006540
Enrollment
Unknown
Registered
2015-06-10
Start date
2012-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vertigo

Interventions

Gold Standard:
Index test:

Sponsors

1st affiliated hospital, Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. do not have an underlying cause encompass recurrent IV with clinical manifestations of semeiology; 2. No focal neurological signs according to two chief physician neurologists; 3. Normal head impulse test; 4. No head trauma; No history of migraine; 5. No acute infarction and hemorrhage or tumor especially involving the posterior fossa circulation in head CT or MRI; 6. No orthostatic hypotension; 7. Exclused inner ear including sudden deafness, liver, kidney, anemia, congenital heart disorders, emotional disease; 8. No history of poisoning; 9. No related drugs that could induce vertigo; 10. No contrast agent contraindications.

Exclusion criteria

Exclusion criteria: 1. Focal neurological signs according to two chief physician neurologists; 2. Abnormal head impulse test; 3. Head trauma; 4. History of migraine; 5. Acute infarction and hemorrhage or tumor especially involving the posterior fossa circulation in head CT or MRI; 6. Orthostatic hypotension; 7. Inner ear including sudden deafness, liver, kidney, anemia, congenital heart disorders, emotional disease; 8. History of poisoning; 9. Related drugs that could induce vertigo; 10. Contrast agent contraindications.

Design outcomes

Primary

MeasureTime frame
intracranial vascular morphological changes;whole-brain perfusion;vascular risk factors;

Countries

China

Contacts

Public ContactHuang Li An
huanglian1306@126.com+86 13005199817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026